Business Description
Bavarian Nordic AS
ISIN : DK0015998017
Compare
Compare
Traded in other countries / regions
BAVA.DenmarkBVNRY.USA0DPB.UKBV3.GermanyBAVA.Austria IPO Date
2022-12-21Description
Bavarian Nordic A/S is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 16.37 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.07 | |||||
| Interest Coverage | 12.72 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.28 | |||||
| Beneish M-Score | -1.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 39 | |||||
| 3-Year EBITDA Growth Rate | 22.6 | |||||
| 3-Year EPS without NRI Growth Rate | 55.8 | |||||
| 3-Year Book Growth Rate | 16.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.47 | |||||
| 9-Day RSI | 30.08 | |||||
| 14-Day RSI | 34.74 | |||||
| 3-1 Month Momentum % | 2.68 | |||||
| 6-1 Month Momentum % | -28.29 | |||||
| 12-1 Month Momentum % | 21.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.69 | |||||
| Quick Ratio | 0.98 | |||||
| Cash Ratio | 0.61 | |||||
| Days Inventory | 235.99 | |||||
| Days Sales Outstanding | 68.44 | |||||
| Days Payable | 101.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 4.83 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.38 | |||||
| Operating Margin % | 18.84 | |||||
| Net Margin % | 18.43 | |||||
| FCF Margin % | 4.6 | |||||
| ROE % | 10.97 | |||||
| ROA % | 8.04 | |||||
| ROIC % | 10.21 | |||||
| 3-Year ROIIC % | 25.31 | |||||
| ROC (Joel Greenblatt) % | 46.48 | |||||
| ROCE % | 11.17 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.89 | |||||
| Forward PE Ratio | 9.45 | |||||
| PE Ratio without NRI | 12.04 | |||||
| Shiller PE Ratio | 248.47 | |||||
| PS Ratio | 2.19 | |||||
| PB Ratio | 1.26 | |||||
| Price-to-Tangible-Book | 3.07 | |||||
| Price-to-Free-Cash-Flow | 45.45 | |||||
| Price-to-Operating-Cash-Flow | 8.42 | |||||
| EV-to-EBIT | 9.28 | |||||
| EV-to-EBITDA | 6.72 | |||||
| EV-to-Revenue | 1.86 | |||||
| EV-to-FCF | 40.6 | |||||
| Price-to-GF-Value | 0.63 | |||||
| Price-to-Median-PS-Value | 0.31 | |||||
| Price-to-Graham-Number | 1.27 | |||||
| Price-to-Net-Current-Asset-Value | 6.8 | |||||
| Earnings Yield (Greenblatt) % | 10.78 | |||||
| FCF Yield % | 2.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bavarian Nordic AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 813.967 | ||
| EPS (TTM) (€) | 1.932 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 55.36 | ||
| 14-Day RSI | 34.74 | ||
| 14-Day ATR (€) | 0.569026 | ||
| 20-Day SMA (€) | 23.2985 | ||
| 12-1 Month Momentum % | 21.56 | ||
| 52-Week Range (€) | 19.35 - 39.43 | ||
| Shares Outstanding (Mil) | 77.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bavarian Nordic AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bavarian Nordic AS Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bavarian Nordic AS Frequently Asked Questions
What is Bavarian Nordic AS(WBO:BAVA)'s stock price today?
The current price of WBO:BAVA is €22.38. The 52 week high of WBO:BAVA is €39.43 and 52 week low is €19.35.
When is next earnings date of Bavarian Nordic AS(WBO:BAVA)?
The next earnings date of Bavarian Nordic AS(WBO:BAVA) is 2025-05-09.
Does Bavarian Nordic AS(WBO:BAVA) pay dividends? If so, how much?
Bavarian Nordic AS(WBO:BAVA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers